SCHEMBL22952965

SCHEMBL22952965

NCC1OC(C2CCCOC2)Cc2c1ccc(O)c2O

nearest known ligand 0.78

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 17/20 0.78
ADRA2A P08913 2/20 0.61
ADRA2B P18089 2/20 0.61
ADRA2C P18825 2/20 0.61
HTR2C P28335 2/20 0.61
SLC6A3 Q01959 2/20 0.61
KDM4E B2RXH2 1/20 0.52
TP53 P04637 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
MAPT P10636 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
HSD17B10 Q99714 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22952913 0.94 DRD1 (0.84) DRD1ADRA2AADRA2BADRA2CHTR2C
SCHEMBL10380336 0.88 DRD1 (1.00) DRD1ADRA2AADRA2BADRA2CHTR2C
SCHEMBL7447221 0.88 DRD1 (1.00) DRD1ADRA2AADRA2BADRA2CHTR2C
SCHEMBL9038117 0.88 DRD1 (1.00) DRD1ADRA2AADRA2BADRA2CHTR2C
SCHEMBL10380050 0.88 DRD1 (1.00) DRD1ADRA2AADRA2BADRA2CHTR2C
Hydrochloric Acid SCHEMBL7317977 0.86 DRD1 (0.97) DRD1ADRA2AADRA2BADRA2CHTR2C
SCHEMBL22952958 0.86 DRD1 (0.79) DRD1ADRA2AADRA2BADRA2CHTR2C
Hydrochloric Acid SCHEMBL8728268 0.86 DRD1 (0.97) DRD1ADRA2AADRA2BADRA2CHTR2C
Hydrochloric Acid SCHEMBL7306224 0.86 DRD1 (0.97) DRD1ADRA2AADRA2BADRA2CHTR2C
SCHEMBL7002535 0.81 DRD1 (0.77) DRD1ADRA2AADRA2BADRA2CHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021021922-A1 COMPOUNDS AND METHODS FOR TREATING FIBROTIC PATHOLOGIES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2021-02-04 WO disclosed